Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 358

1.

Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.

Cowling BJ, Ng S, Ma ES, Cheng CK, Wai W, Fang VJ, Chan KH, Ip DK, Chiu SS, Peiris JS, Leung GM.

Clin Infect Dis. 2010 Dec 15;51(12):1370-9. doi: 10.1086/657311. Epub 2010 Nov 10.

PMID:
21067351
2.

Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial.

Cowling BJ, Ng S, Ma ES, Fang VJ, So HC, Wai W, Cheng CK, Wong JY, Chan KH, Ip DK, Chiu SS, Peiris JS, Leung GM.

Clin Infect Dis. 2012 Sep;55(5):695-702. doi: 10.1093/cid/cis518. Epub 2012 Jun 5.

PMID:
22670050
3.

Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.

Zhou Y, Ng DM, Seto WH, Ip DK, Kwok HK, Ma ES, Ng S, Lau LL, Peiris JS, Cowling BJ.

PLoS One. 2011;6(11):e27169. doi: 10.1371/journal.pone.0027169. Epub 2011 Nov 10.

4.

Possible Impact of Yearly Childhood Vaccination With Trivalent Inactivated Influenza Vaccine (TIV) on the Immune Response to the Pandemic Strain H1N1.

Amer A, Fischer H, Li X, Asmar B.

Clin Pediatr (Phila). 2016 Mar;55(3):245-50. doi: 10.1177/0009922815594357. Epub 2015 Jul 9.

PMID:
26159622
5.

Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.

McVernon J, Laurie K, Barr I, Kelso A, Skeljo M, Nolan T.

Influenza Other Respir Viruses. 2011 Jan;5(1):7-11. doi: 10.1111/j.1750-2659.2010.00172.x. Epub 2010 Aug 24.

6.

Incidence of influenza virus infections in children in Hong Kong in a 3-year randomized placebo-controlled vaccine study, 2009-2012.

Cowling BJ, Perera RA, Fang VJ, Chan KH, Wai W, So HC, Chu DK, Wong JY, Shiu EY, Ng S, Ip DK, Peiris JS, Leung GM.

Clin Infect Dis. 2014 Aug 15;59(4):517-24. doi: 10.1093/cid/ciu356. Epub 2014 May 13.

PMID:
24825868
7.

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.

Vesikari T, Richardus JH, Berglund J, Korhonen T, Flodmark CE, Lindstrand A, Silfverdal SA, Bambure V, Caplanusi A, Dieussaert I, Roy-Ghanta S, Vaughn DW.

Pediatr Infect Dis J. 2015 Jul;34(7):774-82. doi: 10.1097/INF.0000000000000709.

PMID:
26069949
8.

The effect of age and recent influenza vaccination history on the immunogenicity and efficacy of 2009-10 seasonal trivalent inactivated influenza vaccination in children.

Ng S, Ip DK, Fang VJ, Chan KH, Chiu SS, Leung GM, Peiris JS, Cowling BJ.

PLoS One. 2013;8(3):e59077. doi: 10.1371/journal.pone.0059077. Epub 2013 Mar 12.

9.

Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).

Chan TC, Hung IF, Luk JK, Shea YF, Chan FH, Woo PC, Chu LW.

J Am Med Dir Assoc. 2012 Oct;13(8):698-703. doi: 10.1016/j.jamda.2012.05.009. Epub 2012 Jun 20.

PMID:
22722051
10.

Live attenuated seasonal and pandemic influenza vaccine in school-age children: a randomized controlled trial.

Klick B, Durrani S, Chan KH, Ip DK, Chou ES, Kwok HK, Ng S, Chiu SS, Peiris JS, Leung GM, Cowling BJ.

Vaccine. 2013 Apr 8;31(15):1937-43. doi: 10.1016/j.vaccine.2013.02.017. Epub 2013 Feb 19.

PMID:
23434387
11.

Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.

Bateman AC, Kieke BA, Irving SA, Meece JK, Shay DK, Belongia EA.

J Infect Dis. 2013 Apr 15;207(8):1262-9. doi: 10.1093/infdis/jit020. Epub 2013 Jan 22.

PMID:
23341536
12.

Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.

Gilca V, De Serres G, Hamelin ME, Boivin G, Ouakki M, Boulianne N, Sauvageau C, Dionne M, Gilca R, Skowronski D.

Vaccine. 2011 Dec 9;30(1):35-41. doi: 10.1016/j.vaccine.2011.10.062. Epub 2011 Nov 7.

PMID:
22063386
13.

Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.

Weil-Olivier C, Lina B.

Vaccine. 2011 Sep 16;29(40):7075-9. doi: 10.1016/j.vaccine.2011.07.018. Epub 2011 Jul 21.

PMID:
21777639
14.

Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.

Pariani E, Boschini A, Amendola A, Poletti R, Anselmi G, Begnini M, Ranghiero A, Cecconi G, Zanetti AR.

Vaccine. 2011 Nov 15;29(49):9209-13. doi: 10.1016/j.vaccine.2011.09.103. Epub 2011 Oct 3.

PMID:
21974995
15.

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

Langley JM, Scheifele DW, Quach C, Vanderkooi OG, Ward B, McNeil S, Dobson S, Kellner JD, Kuhn S, Kollman T, MacKinnon-Cameron D, Smith B, Li Y, Halperin SA.

Vaccine. 2012 May 14;30(23):3389-94. doi: 10.1016/j.vaccine.2012.03.046. Epub 2012 Mar 30.

PMID:
22469860
16.

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.

McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, Flynn PM.

Clin Infect Dis. 2010 Jun 1;50(11):1487-92. doi: 10.1086/652441.

17.

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.

Jackson LA, Gaglani MJ, Keyserling HL, Balser J, Bouveret N, Fries L, Treanor JJ.

BMC Infect Dis. 2010 Mar 17;10:71. doi: 10.1186/1471-2334-10-71.

18.

Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.

Soonawala D, Rimmelzwaan GF, Gelinck LB, Visser LG, Kroon FP.

PLoS One. 2011 Jan 31;6(1):e16496. doi: 10.1371/journal.pone.0016496.

19.

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Frey SE, Bernstein DI, Brady RC, Keitel WA, El Sahly H, Rouphael NG, Mulligan MJ, Atmar RL, Edupuganti S, Patel SM, Dickey M, Graham I, Anderson EL, Noah DL, Hill H, Wolff M, Belshe RB.

Vaccine. 2015 Jan 1;33(1):163-73. doi: 10.1016/j.vaccine.2014.10.083. Epub 2014 Nov 11.

20.

Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: a one-year prospective cohort study.

Chan TC, Hung IF, Luk JK, Shea YF, Chan FH, Woo PC, Chu LW.

Vaccine. 2011 Oct 13;29(44):7773-8. doi: 10.1016/j.vaccine.2011.07.112. Epub 2011 Aug 5.

PMID:
21821084

Supplemental Content

Support Center